Global HER-2 Targeted Drugs for Breast Cancer Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID :QYR-18541656 | Published Date: 14-Jun-2021 | No. of pages: 118Description
TOC
1 Market Overview of HER-2 Targeted Drugs for Breast Cancer
1.1 HER-2 Targeted Drugs for Breast Cancer Market Overview
1.1.1 HER-2 Targeted Drugs for Breast Cancer Product Scope
1.1.2 HER-2 Targeted Drugs for Breast Cancer Market Status and Outlook
1.2 Global HER-2 Targeted Drugs for Breast Cancer Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2027)
1.4 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Region (2016-2021)
1.5 Global HER-2 Targeted Drugs for Breast Cancer Market Size Forecast by Region (2022-2027)
1.6 Key Regions, HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
1.6.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
1.6.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
1.6.3 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
1.6.4 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
1.6.5 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
2 HER-2 Targeted Drugs for Breast Cancer Market Overview by Type
2.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Type (2016-2021)
2.3 Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Type (2022-2027)
2.4 Trastuzumab
2.5 Pertuzumab
2.6 Lapatinib
2.7 Neratinib
2.8 Trastuzumab Emtansine
2.9 Pyrotinib
2.10 Other
3 HER-2 Targeted Drugs for Breast Cancer Market Overview by Application
3.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Application (2016-2021)
3.3 Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Application (2022-2027)
3.4 Hospital
3.5 Clinic
3.6 Drug Center
3.7 Other
4 HER-2 Targeted Drugs for Breast Cancer Competition Analysis by Players
4.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HER-2 Targeted Drugs for Breast Cancer as of 2020)
4.3 Date of Key Players Enter into HER-2 Targeted Drugs for Breast Cancer Market
4.4 Global Top Players HER-2 Targeted Drugs for Breast Cancer Headquarters and Area Served
4.5 Key Players HER-2 Targeted Drugs for Breast Cancer Product Solution and Service
4.6 Competitive Status
4.6.1 HER-2 Targeted Drugs for Breast Cancer Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.1.4 Roche HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.1.5 Roche Recent Developments
5.2 Chugai Pharmaceutical
5.2.1 Chugai Pharmaceutical Profile
5.2.2 Chugai Pharmaceutical Main Business
5.2.3 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.2.4 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.2.5 Chugai Pharmaceutical Recent Developments
5.3 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.3.2 GlaxoSmithKline Main Business
5.3.3 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.3.4 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.4.4 Novartis HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.4.5 Novartis Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.5.4 Pfizer HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.5.5 Pfizer Recent Developments
5.6 CANbridge
5.6.1 CANbridge Profile
5.6.2 CANbridge Main Business
5.6.3 CANbridge HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.6.4 CANbridge HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.6.5 CANbridge Recent Developments
5.7 Puma Biotechnology
5.7.1 Puma Biotechnology Profile
5.7.2 Puma Biotechnology Main Business
5.7.3 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.7.4 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.7.5 Puma Biotechnology Recent Developments
5.8 Hengrui Medicine
5.8.1 Hengrui Medicine Profile
5.8.2 Hengrui Medicine Main Business
5.8.3 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.8.4 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.8.5 Hengrui Medicine Recent Developments
5.9 Beacon Pharmaceuticals Limited
5.9.1 Beacon Pharmaceuticals Limited Profile
5.9.2 Beacon Pharmaceuticals Limited Main Business
5.9.3 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.9.4 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.9.5 Beacon Pharmaceuticals Limited Recent Developments
5.10 Hetero Drugs
5.10.1 Hetero Drugs Profile
5.10.2 Hetero Drugs Main Business
5.10.3 Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.10.4 Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.10.5 Hetero Drugs Recent Developments
6 North America
6.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 HER-2 Targeted Drugs for Breast Cancer Market Dynamics
11.1 HER-2 Targeted Drugs for Breast Cancer Industry Trends
11.2 HER-2 Targeted Drugs for Breast Cancer Market Drivers
11.3 HER-2 Targeted Drugs for Breast Cancer Market Challenges
11.4 HER-2 Targeted Drugs for Breast Cancer Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Tables & Figures
List of Tables
Table 1. Global Market HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global HER-2 Targeted Drugs for Breast Cancer Market Size Share by Region (2016-2021)
Table 4. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size Share by Region (2022-2027)
Table 6. Global HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2016-2021)
Table 9. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2022-2027)
Table 11. Global HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Application (2016-2021)
Table 14. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Application (2022-2027)
Table 16. Global HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) by Players (2016-2021)
Table 17. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HER-2 Targeted Drugs for Breast Cancer as of 2020)
Table 19. Date of Key Manufacturers Enter into HER-2 Targeted Drugs for Breast Cancer Market
Table 20. Global HER-2 Targeted Drugs for Breast Cancer Top Players Headquarters and Area Served
Table 21. HER-2 Targeted Drugs for Breast Cancer Product Solution and Service
Table 22. Global HER-2 Targeted Drugs for Breast Cancer Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Roche Basic Information List
Table 25. Roche Description and Business Overview
Table 26. Roche HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 27. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Roche (2016-2021)
Table 28. Roche Recent Developments
Table 29. Chugai Pharmaceutical Basic Information List
Table 30. Chugai Pharmaceutical Description and Business Overview
Table 31. Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 32. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Chugai Pharmaceutical (2016-2021)
Table 33. Chugai Pharmaceutical Recent Developments
Table 34. GlaxoSmithKline Basic Information List
Table 35. GlaxoSmithKline Description and Business Overview
Table 36. GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 37. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of GlaxoSmithKline (2016-2021)
Table 38. GlaxoSmithKline Recent Developments
Table 39. Novartis Basic Information List
Table 40. Novartis Description and Business Overview
Table 41. Novartis HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 42. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Novartis (2016-2021)
Table 43. Novartis Recent Developments
Table 44. Pfizer Basic Information List
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 47. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Pfizer (2016-2021)
Table 48. Pfizer Recent Developments
Table 49. CANbridge Basic Information List
Table 50. CANbridge Description and Business Overview
Table 51. CANbridge HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 52. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of CANbridge (2016-2021)
Table 53. CANbridge Recent Developments
Table 54. Puma Biotechnology Basic Information List
Table 55. Puma Biotechnology Description and Business Overview
Table 56. Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 57. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Puma Biotechnology (2016-2021)
Table 58. Puma Biotechnology Recent Developments
Table 59. Hengrui Medicine Basic Information List
Table 60. Hengrui Medicine Description and Business Overview
Table 61. Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 62. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Hengrui Medicine (2016-2021)
Table 63. Hengrui Medicine Recent Developments
Table 64. Beacon Pharmaceuticals Limited Basic Information List
Table 65. Beacon Pharmaceuticals Limited Description and Business Overview
Table 66. Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 67. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Beacon Pharmaceuticals Limited (2016-2021)
Table 68. Beacon Pharmaceuticals Limited Recent Developments
Table 69. Hetero Drugs Basic Information List
Table 70. Hetero Drugs Description and Business Overview
Table 71. Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 72. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Hetero Drugs (2016-2021)
Table 73. Hetero Drugs Recent Developments
Table 74. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 75. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 76. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 77. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 78. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 79. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 80. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Region (2016-2021)
Table 81. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Region (2022-2027)
Table 82. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 83. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 84. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Players (2016-2021) & (US$ Million)
Table 85. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 86. HER-2 Targeted Drugs for Breast Cancer Market Trends
Table 87. HER-2 Targeted Drugs for Breast Cancer Market Drivers
Table 88. HER-2 Targeted Drugs for Breast Cancer Market Challenges
Table 89. HER-2 Targeted Drugs for Breast Cancer Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER-2 Targeted Drugs for Breast Cancer Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Regions: 2021 VS 2027
Figure 4. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global HER-2 Targeted Drugs for Breast Cancer Market Size Share by Type in 2021 & 2027
Figure 11. Trastuzumab Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Pertuzumab Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Lapatinib Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. Neratinib Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Trastuzumab Emtansine Market Size (US$ Million) YoY Growth (2016-2027)
Figure 16. Pyrotinib Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Global HER-2 Targeted Drugs for Breast Cancer Market Size Share by Application in 2021 & 2027
Figure 18. Hospital Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Clinic Market Size (US$ Million) YoY Growth (2016-2027)
Figure 20. Drug Center Market Size (US$ Million) YoY Growth (2016-2027)
Figure 21. Other Market Size (US$ Million) YoY Growth (2016-2027)
Figure 22. HER-2 Targeted Drugs for Breast Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Top 5 and Top 10 Players HER-2 Targeted Drugs for Breast Cancer Market Share in 2020
Figure 24. North America HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
Figure 25. United States HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 26. Canada HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 27. Germany HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 28. France HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 29. U.K. HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 30. Italy HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 31. Russia HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 32. Nordic HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 33. Rest of Europe HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Region (2016-2027)
Figure 35. China HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 36. Japan HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 37. South Korea HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 38. Southeast Asia HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 39. India HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 40. Australia HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 41. Rest of Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 42. Latin America HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
Figure 43. Mexico HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 44. Brazil HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 45. Rest of Latin America HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 46. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
Figure 47. Turkey HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 48. Saudi Arabia HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 49. UAE HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 50. Rest of Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Companies
Roche
Chugai Pharmaceutical
GlaxoSmithKline
Novartis
Pfizer
CANbridge
Puma Biotechnology
Hengrui Medicine
Beacon Pharmaceuticals Limited
Hetero Drugs
- PRICE
-
$3350$6700$5025Buy Now